Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Manufacturing	7.83B	6.51B	10.32B	12.53B	10.12B
Pharmaceutical Manufacturing Growth	20.24%	-36.88%	-17.67%	23.88%	15.19%
Total	7.83B	6.51B	10.32B	12.53B	10.12B
Total Growth	20.24%	-36.88%	-17.67%	23.88%	15.19%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016
China	7.53B	6.22B	10.08B	12.07B	9.76B
China Growth	21.08%	-38.31%	-16.50%	23.67%	15.12%
Overseas	302.37M	294.91M	239.34M	462.58M	356.64M
Overseas Growth	2.53%	23.22%	-48.26%	29.71%	17.23%
Total	7.83B	6.51B	10.32B	12.53B	10.12B
Total Growth	20.24%	-36.88%	-17.67%	23.88%	15.19%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error